These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3172175)

  • 21. Properdin deficiency in a family with fulminant meningococcal infections.
    Sjöholm AG; Braconier JH; Söderström C
    Clin Exp Immunol; 1982 Nov; 50(2):291-7. PubMed ID: 7151327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC; Peters DK
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation of the complement system in clinical practice].
    Frémeaux-Bacchi V; Dragon-Durey MA; Blouin J; Mouthon L; Fridman WH
    Ann Med Interne (Paris); 2003 Dec; 154(8):529-40. PubMed ID: 15037829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Occurrence of complement defects in meningococcal disease: who should be examined?].
    Nielsen HE; Magnussen P; Lind I
    Ugeskr Laeger; 1991 Apr; 153(16):1113-6. PubMed ID: 1902602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical findings and genetic bases of congenital complement deficiencies].
    Kira R; Ihara K; Takada H; Hara J
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Apr; 22(2):53-62. PubMed ID: 11126655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum factors and polymorphonuclear leukocytes in human host defence against Neisseria meningitidis. Studies of interactions with special reference to a chemiluminometric technique.
    Fredlund H
    Scand J Infect Dis Suppl; 1993; 87():1-72. PubMed ID: 8511525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningococcal surrogates of protection--serum bactericidal antibody activity.
    Borrow R; Balmer P; Miller E
    Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meningococcal disease--management of serogroup C clusters in a hyperendemic area.
    Dell E; Bedford D; McMahon B; Nicholson A
    Ir Med J; 2001 Jun; 94(6):166, 168-9. PubMed ID: 11495231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
    Raghunathan PL; Jones JD; Tiendrebéogo SR; Sanou I; Sangaré L; Kouanda S; Dabal M; Lingani C; Elie CM; Johnson S; Ari M; Martinez J; Chatt J; Sidibe K; Schmink S; Mayer LW; Kondé MK; Djingarey MH; Popovic T; Plikaytis BD; Carlone GM; Rosenstein N; Soriano-Gabarró M
    J Infect Dis; 2006 Mar; 193(5):607-16. PubMed ID: 16453255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.
    Baker PJ; Adler S; Yang Y; Couser WG
    J Immunol; 1984 Aug; 133(2):877-81. PubMed ID: 6376629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report.
    Grimnes G; Beckman H; Lappegård KT; Mollnes TE; Skogen V
    APMIS; 2011 Jul; 119(7):479-84. PubMed ID: 21635555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic meningococcal infections in patients with acquired complement deficiency.
    Garty BZ; Nitzan M; Danon YL
    Pediatr Allergy Immunol; 1993 Feb; 4(1):6-9. PubMed ID: 8348257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement deficiency states and meningococcal disease.
    Figueroa J; Andreoni J; Densen P
    Immunol Res; 1993; 12(3):295-311. PubMed ID: 8288947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and epidemiological implications of meningococcal disease.
    Meredith ; Galwankar S
    J Assoc Physicians India; 2005 Jul; 53():628-33. PubMed ID: 16190134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.
    Ruley EJ; Forristal J; Davis NC; Andres C; West CD
    J Clin Invest; 1973 Apr; 52(4):896-904. PubMed ID: 4693654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of a benign subtype of dense deposit disease: comparison with the progressive form of this disease.
    Klein M; Poucell S; Arbus GS; McGraw M; Rance CP; Yoon SJ; Baumal R
    Clin Nephrol; 1983 Oct; 20(4):163-71. PubMed ID: 6556977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of complement deficiencies.
    Pettigrew HD; Teuber SS; Gershwin ME
    Ann N Y Acad Sci; 2009 Sep; 1173():108-23. PubMed ID: 19758139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.